| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.2411 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.1079 | 56 |
| GSM780709 | Untreated after 4 days (C3_1) | 54.5501 | 59 |
| GSM780719 | Untreated after 4 days (C1_2) | 56.6412 | 62 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.4592 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 56.6664 | 62 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.4085 | 53 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 57.0201 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.9856 | 41 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 54.4436 | 59 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.7679 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 52.7277 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 46.6266 | 35 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.5827 | 43 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 54.8481 | 59 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.7212 | 51 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 55.417 | 60 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.4158 | 57 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.1627 | 52 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 52.3083 | 55 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 52.2985 | 55 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 49.112 | 45 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 53.7092 | 57 |